SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,310.01 2,008.61
( 2.60%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,776.27 -52.94
(-0.49%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

97.3802066

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

122.06

426121.89

EPS(TTM)

Face Value()

Div & Yield %

14.55

0.9

Back

TAAL Tech consolidated net profit rises 48.77% in the September 2026 quarter

Nov 03,2026

Net profit of TAAL Tech rose 48.77% to Rs 21.23 crore in the quarter ended September 2026 as against Rs 14.27 crore during the previous quarter ended September 2025. Sales rose 40.55% to Rs 68.63 crore in the quarter ended September 2026 as against Rs 48.83 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	68.63	48.83	41
OPM %	34.62	31.03	-
PBDT	28.72	20.29	42
PBT	27.91	19.30	45
NP	21.23	14.27	49

79,310.01 2,008.61 ( 2.60%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

60,935.13 -1,253.50 (-2.02%)

10,776.27 -52.94 (-0.49%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)